The reason Apt-Dox could enter CD19-positive lymphoma cells was presumably that the aptamer recognized and bound to the CD19 structure on CD19-positive cells, resulting in the endocytosis of the Apt-Dox complex. The gene discussed is CD19; the disease is lymphoma.